Logo

American Heart Association

  9
  0


Final ID: TP19

Intravenous thrombolysis before inter-facility transfer for thrombectomy

Abstract Body: Background: Patients with acute ischemic stroke and a large vessel occlusion (LVO) admitted to primary stroke centers (PSC) often require inter-facility transfer for thrombectomy. We aimed to study the efficacy and safety of intravenous thrombolysis (IVT) use before transfer.

Methods: We retrospectively analyzed data from two prospective cohorts of acute stroke patients with an anterior circulation LVO transferred for thrombectomy from a PSC, regardless of whether thrombectomy was eventually attempted in the endovascular-capable center. The primary efficacy outcome was good 3-month functional outcome, defined as a modified Rankin scale (mRS) 0-2. Secondary efficacy outcomes were excellent 3-month functional outcome (mRS 0-1) and arterial recanalization during transfer. Safety outcomes were any intracerebral hemorrhage (ICH) and symptomatic ICH (sICH) at 24-36hrs. We used propensity score with overlap weighting to reduce baseline differences between patients treated with IVT vs those without.

Results: A total of 521 patients were included, of whom 260 (50%) received IVT before transfer. The main reasons for withholding IVT were being outside the 4.5hr time-window (56%) and anticoagulants use (21%). Median age was 72 years, 55% were men, median baseline NIHSS was 15 and occlusion site was intracranial carotid in 21%, M1 in 61% and M2 in 18%. Good functional outcome occurred in 37% of patients. After propensity score with overlap weighting, all baseline variables were well balanced between the two groups. Compared with patients not treated with IVT, those receiving IVT more frequently had good functional outcome (OR=2.31; 95%CI 1.52-3.51; P<0.01), excellent functional outcome (OR=1.99; 1.21-3.27; P<0.01), and inter-facility recanalization (OR=5.64; 2.91-10.92; P<0.01). There were no significant between-groups differences for any ICH (OR=1.16; 0.78-1.73; P=0.47) and sICH (OR=0.65; 0.31-1.38; P=0.26).

Conclusion: IVT before inter-facility transfer for thrombectomy is associated with improved functional outcome, without safety concerns. Broadening IVT indications in PSCs may improve clinical recovery.
  • Seners, Pierre  ( Rothschild Foundation Hospital , Paris , France )
  • Albers, Greg  ( Stanford University , Stanford , California , United States )
  • Ter Schiphorst, Adrien  ( Montpellier University Hospital , Montpellier , France )
  • Wouters, Anke  ( UZ LEUVEN NEUROLOGY , Leuven , Belgium )
  • Mlynash, Michael  ( Stanford University Medical Center , Palo Alto , California , United States )
  • Yuen, Nicole  ( Stanford University , Mountain View , California , United States )
  • Arquizan, Caroline  ( Montpellier University Hospital , Montpellier , France )
  • Heit, Jeremy  ( Stanford University , Palo Alto , California , United States )
  • Costalat, Vincent  ( CHU de MONTPELLIER , MONTPELLIER , France )
  • Lansberg, Maarten  ( STANFORD UNIVERSITY , Palo Alto , California , United States )
  • Author Disclosures:
    Pierre Seners: DO have relevant financial relationships ; Speaker:ACTICOR Biotech:Past (completed) ; Speaker:Boerhinger Ingelheim:Expected (by end of conference) | Greg Albers: DO have relevant financial relationships ; Consultant:iSchemaView:Active (exists now) ; Consultant:Genentech:Past (completed) ; Ownership Interest:iSchemaView:Active (exists now) | Adrien ter Schiphorst: DO NOT have relevant financial relationships | Anke Wouters: DO NOT have relevant financial relationships | Michael Mlynash: DO NOT have relevant financial relationships | Nicole Yuen: DO NOT have relevant financial relationships | Caroline Arquizan: No Answer | Jeremy Heit: DO have relevant financial relationships ; Consultant:Medtronic:Active (exists now) ; Ownership Interest:Dragon Medical:Active (exists now) ; Research Funding (PI or named investigator):NIH:Active (exists now) ; Consultant:Balt:Active (exists now) ; Consultant:MicroVention:Active (exists now) | VINCENT COSTALAT: No Answer | Maarten Lansberg: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Up To Date (Author):Active (exists now) ; Consultant:Biogen:Past (completed) ; Consultant:Roche:Past (completed)
Meeting Info:
Session Info:

Acute Treatment: Systemic Thrombolysis and Cerebroprotection Posters II

Thursday, 02/06/2025 , 07:00PM - 07:30PM

Poster Abstract Session

More abstracts on this topic:
Automated Identification of Stroke Thrombolysis Contraindications from Synthetic Clinical Notes

Chen Bing Yu, Hussain Muhammad, Gonzalez Marco, Antaki Fares, Delora Adam, Aube Eric, Albahra Samer, Robertson Scott, Uchino Ken, Russman Andrew

A Retrospective Study to Determine Opportunities to Improve Earlier EMS Activation for Transport of Patients with Large Vessel Occlusion to Thrombectomy Centers

Maria Shannon, Mojares Joseph, Zrelak Patricia

More abstracts from these authors:
Functional outcome after endovascular treatment can be predicted using deep learning based CT volume and density measures with and without CTP before interhospital transfer

Van Voorst Henk, Mlynash Michael, Zaharchuk Greg, Lansberg Maarten, Albers Greg, Heit Jeremy, Liu Yongkai, Zamarud Aroosa, Wouters Anke, Seners Pierre, Mahammedi Abdelkader, Verhaaren Benjamin, Christensen Soren, Yuen Nicole

Acute Ischemic Stroke Patient Factors Associated with Poor Outcomes in Patients with Favorable Collaterals and Successful Thrombectomy

Kesten Jamie, Mlynash Michael, Yuen Nicole, Seners Pierre, Wouters Anke, Schwartz Maya, Lansberg Maarten, Albers Gregory, Heit Jeremy

You have to be authorized to contact abstract author. Please, Login
Not Available

Readers' Comments

We encourage you to enter the discussion by posting your comments and questions below.

Presenters will be notified of your post so that they can respond as appropriate.

This discussion platform is provided to foster engagement, and simulate conversation and knowledge sharing.

 

You have to be authorized to post a comment. Please, Login or Signup.


   Rate this abstract  (Maximum characters: 500)